Apellis Pharmaceuticals Reports Second Quarter 2019 Business Update and Financial Results

NEXT STORY
Valneva Reports H1 2019 Results Marked by Strong Operational Performance and Major Corporate Progress
PREV STORY
Spring Bank Pharmaceuticals Reports Second Quarter 2019 Financial and Operational Results and Provides Business Development Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors

author_avatar
NASDAQ Market News

Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials

author_avatar
NASDAQ Market News

Inventiva announces major recruitments to accelerate the development of lanifibranor in NASH

author_avatar
NASDAQ Market News